Read about our views on marketplace changes as well as updates on our research and event programmes.

With personal health records from the likes of Google and Microsoft heralding the beginning of a new information enabled era, Janssen (Johnson & Johnson's pharmaceutical company) has been rethinking how to tackle one of the world's best known killers: HIV. Instead of taking a ‘more drugs' approach, they are helping patients live healthier, longer via tailored personalized information about their treatment, based on information they volunteer - what we'd call Volunteered Personal Information.

The service is still in its early stages - the business benefits have yet to be specifically tied down (see below). That said, the general direction of…